InsidersTradesSigma
Discover the detailed record of transactions filed by Tord Staffan Håkan Skogvall, Chief Executive Officer. Director active across 2 companies, notably PharmaLundensis AB. In total, 4 reports have been published. Activity tracked since 6 March 2025. The latest transaction was disclosed on 20 February 2026 (Purchase). Regulator: FIN-FSA. The full history is openly available.
4 of 4 declarations
Tord Staffan Håkan Skogvall is the CEO of PharmaLundensis AB. He is responsible for the overall direction of the company, overseeing operations and implementing strategy. His leadership is crucial for the organization's success.